Coverage

Brighter

Brighter

Trading in warrants series TO3 2017/2020 commences on May 29, 2017.

14:30 / 26 May 2017 Brighter Press release

On Monday, May 29, 2017, Brighter AB's ("Brighter") warrants of series TO3 2017/2020, which was announced in conjunction with Brighter convertible notes series KV1 2017/2018 in April 2017, will be listed for trading.

Terms of the warrants in brief:
  • Series TO3 warrants will be listed for trading on NASDAQOMX First North as of May 29, 2017.
  • Holding of one (1) warrants of series TO3 entitle the holder to subscribe for one (1) new share at a price of 5.12 SEK.
  • Subscription of shares on the basis of the warrants may take place during the following periods:
  • October 11, 2017 through October 25, 2017;
  • April 11, 2018 through April 25, 2018;
  • October 11, 2018 through October 25, 2018;
  • April 11, 2019 through April 25, 2019;
  • October 11, 2019 through October 25, 2019;
  • April 10, 2020 through April 24, 2020.

  • Holders of warrants series TO3 2017/2020 for a total value of SEK 500,000 or more may always exercise the warrants for subscription of shares.

  • Warrants of series TO3 have ISIN code SE0009947633.

For terms and conditions of the Warrants, please visit:

http://brighter.se/en/investors/documents/.  

About Brighter AB (publ)

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter's cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375).

Visit our website and subscribe to press releases: www.brighter.se (http://brighter.se/en/press/press-releases/)

Follow us on:   (http://www.facebook.com/brightercompany)

www.introduce.se

Certified Adviser

Brighter's Certified Adviser on Nasdaq OMX First North is Remium Nordic AB +46 (0)8 - 454 32 50, CorporateFinance@remium.com, www.remium.com.

For further information, please contact:

Henrik Norström, COO

Telephone: +46 733 40 30 45

Email: henrik.norstrom@brighter.se

Truls Sjöstedt, CEO

Telephone : +46 709 73 46 00

Email: truls.sjostedt@brighter.se

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 14:30 CET on May 26 2016.

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/